Currently in shortage
High demand following TGA approval. Eli Lilly unable to meet Australian demand at launch volumes. All doses affected.
Expected resolution: 31 December 2026
tirzepatide
Mounjaro
5 mg/dose · injection · GLP-1 Agonists
PBS Pricing
| General patient co-payment | $31.60 |
| Concession co-payment | $7.70 |
| Full dispensed price | $420.00 |
PBS Information
- Item code
- 5555E
- Drug name
- tirzepatide
- Brand name
- Mounjaro
- Manufacturer
- Eli Lilly
- Formulation
- injection
- Strength
- 5 mg/dose
- Max quantity
- 4 units
- Max repeats
- 5
- PBS listed
- No
- Therapeutic group
- GLP-1 Agonists
TGA Reference: TGA-MSI-2025-013 · Sponsor: Eli Lilly Australia Pty Ltd
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.